Office of digital transformation (ODT) FY24 strategic portfolio management support
Ended Awarded Last action
- Contract number
- 75F40124F19009
- Awardee
-
Deloitte Consulting LLP UEI CKV2L9GZKJK3
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $407,024
Award facts
- Opportunity
-
- 75F40124Q00267 Solicitation number
- Contract value 100% obligated
- $407,023.99 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541611 Administrative Management and General Management Consulting Services
- PSC
- R699 Support- Administrative: Other
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Labor Hours
- Place of performance
- Arlington, VA 22209, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$11 | |
| Original award | $407,035 |
About this award
Deloitte Consulting LLP was awarded a Blanket Purchase Agreement (BPA) call valued at $407,023.99 by the Food and Drug Administration's Office of Digital Transformation to provide strategic portfolio management support through July 16, 2025. The contract is structured on a labor hours pricing model and will be performed in Rosslyn, Virginia. This award is issued without a small business set-aside, reflecting Deloitte's status as a large business prime contractor. The work supports the FDA's digital transformation initiatives, enabling the agency to leverage external consulting expertise in portfolio management and strategic planning to enhance operational efficiency and mission delivery.
This award represents a task order or delivery order under one of Deloitte's existing indefinite delivery vehicles, consistent with the company's substantial federal contracting footprint across civilian and defense agencies. Deloitte maintains numerous master contracts and BPAs that enable federal agencies to procure professional services on a flexible basis, including the $999.99 billion OASIS+ Unrestricted Indefinite Delivery/Indefinite Quantity contract and multiple agency-specific agreements. The FDA engagement aligns with Deloitte's core competencies in IT modernization, program management, and organizational transformation, areas in which the firm has demonstrated extensive experience supporting federal mission-critical initiatives across the government.
Quick answers
Who was awarded contract 75F40124F19009?
75F40124F19009 was awarded to Deloitte Consulting LLP by Food and Drug Administration (Department of Health and Human Services) on July 16, 2024.
How much is contract 75F40124F19009 worth?
The government has obligated $407,024 on 75F40124F19009.
Is contract 75F40124F19009 an order under another contract?
Yes. 75F40124F19009 is a BPA call under 47QRAA18D001P-75F40121A00003, a blanket purchase agreement, on Multiple Award Schedule (MAS).
Was contract 75F40124F19009 competed?
The extent of competition for 75F40124F19009 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award